104 related articles for article (PubMed ID: 25744293)
1. A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort.
Dartois L; Gauthier É; Heitzmann J; Baglietto L; Michiels S; Mesrine S; Boutron-Ruault MC; Delaloge S; Ragusa S; Clavel-Chapelon F; Fagherazzi G
Breast Cancer Res Treat; 2015 Apr; 150(2):415-26. PubMed ID: 25744293
[TBL] [Abstract][Full Text] [Related]
2. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
3. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
[TBL] [Abstract][Full Text] [Related]
5. Progestagens use before menopause and breast cancer risk according to histology and hormone receptors.
Fabre A; Fournier A; Mesrine S; Gompel A; Desreux J; Berrino F; Boutron-Ruault MC; Romieu I; Clavel-Chapelon F
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2723-8. PubMed ID: 18843015
[TBL] [Abstract][Full Text] [Related]
6. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking in relation to risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.
Kabat GC; Kim M; Kakani C; Tindle H; Wactawski-Wende J; Ockene JK; Luo J; Wassertheil-Smoller S; Rohan TE
Am J Epidemiol; 2010 Sep; 172(5):591-9. PubMed ID: 20679068
[TBL] [Abstract][Full Text] [Related]
8. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
[TBL] [Abstract][Full Text] [Related]
9. Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort.
Fagherazzi G; Guillas G; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
Eur J Cancer Prev; 2013 Jan; 22(1):29-37. PubMed ID: 22694827
[TBL] [Abstract][Full Text] [Related]
10. Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort.
Danjou AM; Fervers B; Boutron-Ruault MC; Philip T; Clavel-Chapelon F; Dossus L
Breast Cancer Res; 2015 Mar; 17():39. PubMed ID: 25849111
[TBL] [Abstract][Full Text] [Related]
11. Influence of estrogen plus testosterone supplementation on breast cancer.
Ness RB; Albano JD; McTiernan A; Cauley JA
Arch Intern Med; 2009 Jan; 169(1):41-6. PubMed ID: 19139322
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age.
MacKarem G; Roche CA; Hughes KS
Breast J; 2001; 7(1):34-9. PubMed ID: 11348413
[TBL] [Abstract][Full Text] [Related]
13. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
[TBL] [Abstract][Full Text] [Related]
14. Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique.
Takada M; Sugimoto M; Ohno S; Kuroi K; Sato N; Bando H; Masuda N; Iwata H; Kondo M; Sasano H; Chow LW; Inamoto T; Naito Y; Tomita M; Toi M
Breast Cancer Res Treat; 2012 Jul; 134(2):661-70. PubMed ID: 22689089
[TBL] [Abstract][Full Text] [Related]
15. Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis.
Lumachi F; Frigo AC; Basso U; Tombolan V; Ermani M
Menopause; 2010; 17(3):524-8. PubMed ID: 20130492
[TBL] [Abstract][Full Text] [Related]
16. Active smoking and breast cancer risk: original cohort data and meta-analysis.
Gaudet MM; Gapstur SM; Sun J; Diver WR; Hannan LM; Thun MJ
J Natl Cancer Inst; 2013 Apr; 105(8):515-25. PubMed ID: 23449445
[TBL] [Abstract][Full Text] [Related]
17. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
[TBL] [Abstract][Full Text] [Related]
18. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.
Rockhill B; Spiegelman D; Byrne C; Hunter DJ; Colditz GA
J Natl Cancer Inst; 2001 Mar; 93(5):358-66. PubMed ID: 11238697
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk assessment in women aged 70 and older.
Vacek PM; Skelly JM; Geller BM
Breast Cancer Res Treat; 2011 Nov; 130(1):291-9. PubMed ID: 21604157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
